A detailed history of Tag Stone Capital, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Tag Stone Capital, Inc. holds 518 shares of LLY stock, worth $467,603. This represents 0.27% of its overall portfolio holdings.

Number of Shares
518
Previous 514 0.78%
Holding current value
$467,603
Previous $399,000 17.29%
% of portfolio
0.27%
Previous 0.24%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $2,899 - $3,636
4 Added 0.78%
518 $468,000
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $592 - $792
1 Added 0.19%
514 $399,000
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $525 - $619
1 Added 0.2%
513 $299,000
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $434 - $599
1 Added 0.2%
512 $275,000
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $179,228 - $239,648
511 New
511 $240,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tag Stone Capital, Inc. Portfolio

Follow Tag Stone Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tag Stone Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tag Stone Capital, Inc. with notifications on news.